FinTech
Invex Therapeutics: Receives green light for IIH trial in NZ
Invex Therapeutics Receives green light for IIH trial in NZInvex Therapeutics (IXC) will commence its IIH EVOLVE Phase III clinical trial after receiving...
FinTech
Invex Therapeutics: Receives UK approval to start phase III Presendin trial
Invex Therapeutics Receives UK approval to start phase III Presendin trialInvex Therapeutics (IXC) gets the tick of approval to start its phase III...
Business
Invex Therapeutics: Receives EMA advice on Presendin treatment
Invex Therapeutics: Receives EMA advice on Presendin treatmentThe European Medical Agency has advised a single study on the drug will likely be sufficient...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read